Biology Reference
In-Depth Information
139 Kralovics R, Indrak K, Stopka T, Berman BW, Prchal JF, Prchal JT (1997) Two new EPO recep-
tor mutations: truncated EPO receptors are most frequently associated with primary familial and
congenital polycythemias.
Blood
90: 2057-2061
140 Kralovics R, Sokol L, Prchal JT (1998) Absence of polycythemia in a child with a unique ery-
thropoietin receptor mutation in a family with autosomal dominant primary polycythemia.
J Clin
Invest
102: 124-129
141 Kralovics R, Prchal JT (2001) Genetic heterogeneity of primary familial and congenital poly-
cythemia.
Am J Hematol
68: 115-121
142 Arcasoy MO, Degar BA, Harris KW, Forget BG (1997) Familial erythrocytosis associated with a
short deletion in the erythropoietin receptor gene.
Blood
89: 4628-4635
143 Arcasoy MO, Karayal AF, Segal HM, Sinning JG, Forget BG (2002) A novel mutation in the ery-
thropoietin receptor gene is associated with familial erythrocytosis.
Blood
99: 3066-3069
144 Furukawa T, Narita M, Sakaue M, Otsuka T, Kuroha T, Masuko M, Azegami T, Kishi K,
Takahashi M, Utsumi J et al. (1997) Primary familial polycythaemia associated with a novel point
mutation in the erythropoietin receptor.
Br J Haematol
99: 222-227
145 Qu CK, Shi ZQ, Shen R, Tsai FY, Orkin SH, Feng GS (1997) A deletion mutation in the SH2-N
domain of Shp-2 severely suppresses hematopoietic cell development.
Mol Cell Biol
17:
5499-5507
146 Qu CK, Yu WM, Azzarelli B, Cooper S, Broxmeyer HE, Feng GS (1998) Biased suppression of
hematopoiesis and multiple developmental defects in chimeric mice containing Shp-2 mutant
cells.
Mol Cell Biol
18: 6075-6082
147 Helgason CD, Damen JE, Rosten P, Grewal R, Sorensen P, Chappel SM, Borowski A, Jirik F,
Krystal G, Humphries RK (1998) Targeted disruption of SHIP leads to hemopoietic perturba-
tions, lung pathology, and a shortened life span.
Genes Dev
12: 1610-1620
148 Kishihara K, Penninger J, Wallace VA, Kundig TM, Kawai K, Wakeham A, Timms E, Pfeffer K,
Ohashi PS, Thomas ML et al. (1993) Normal B lymphocyte development but impaired T cell
maturation in CD45-exon6 protein tyrosine phosphatase-deficient mice.
Cell
74: 143-156
149 Byth KF, Conroy LA, Howlett S, Smith AJ, May J, Alexander DR, Holmes N (1996) CD45-null
transgenic mice reveal a positive regulatory role for CD45 in early thymocyte development, in the
selection of CD4+CD8+ thymocytes, and B cell maturation.
J Exp Med
183: 1707-1718
150 Irie-Sasaki J, Sasaki T, Matsumoto W, Opavsky A, Cheng M, Welstead G, Griffiths E, Krawczyk
C, Richardson CD, Aitken K et al. (2001) CD45 is a JAK phosphatase and negatively regulates
cytokine receptor signalling.
Nature
409:349-354
151 Lansdorp PM, Sutherland HJ, Eaves CJ (1990) Selective expression of CD45 isoforms on func-
tional subpopulations of CD34+ hemopoietic cells from human bone marrow.
J Exp Med
172:
363-366
152 Craig W, Poppema S, Little MT, Dragowska W, Lansdorp PM (1994) CD45 isoform expression
on human haemopoietic cells at different stages of development.
Br J Haematol
88: 24-30
